Cuba vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Cuba
100.0%
in 2024
Georgia
100.0%
in 2024
Cuba rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cuba
- Georgia
How they compare
Cuba currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 10 times across 20 shared years of data; in 2004 it was Georgia ahead.
Cuba ranks 1st and Georgia ranks 1st of 144 countries.
Across the 3 decades both report, Cuba averaged higher in 2 and Georgia in 1.
Head to head by decade
| Decade | Cuba | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.4% | 71.8% | 7.6% | Cuba |
| 2010s | 88.0% | 89.8% | 1.8% | Georgia |
| 2020s | 99.0% | 96.6% | 2.4% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cuba or Georgia?
- Cuba, at 100.0% against 100.0% in Georgia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cuba and Georgia?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Georgia?
- 20 years are reported by both, from 2004 to 2024.
- How do Cuba and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cuba ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.